Fatty Liver: all 1,462 studies

Page 5 of 15. Open to participants first (289), then studies with results posted, then the rest; newest registration first within each.

• EUS Guided Core Liver Biopsy and IGB Placement for the Diagnosis and Management of NASH and ObesityCompletedNCT02880189Not applicableResults posted
• Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD)CompletedNCT02875392Not applicableResults posted
• Study to Evaluate Safety, Tolerability, and Efficacy of GS-0976 in Adults With Nonalcoholic SteatohepatitisCompletedNCT02856555Phase 2Results posted
• Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)TerminatedNCT02855164Phase 2Results posted
• Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)CompletedNCT02854605Phase 2Results posted
• Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic FunctionCompletedNCT02808312Phase 1Results posted
• Controlled Attenuation Parameter (CAP) in Liver AllograftsCompletedNCT02798861Results posted
• Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)TerminatedNCT02787304Phase 2Results posted
• Evaluate Patients With Chronic Hepatitis by Three-dimensional Force-controlled Ultrasound MeasurementCompletedNCT02784925Not applicableResults posted
• A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASHCompletedNCT02784444Phase 2Results posted
• Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)CompletedNCT02781584Phase 2Results posted
• Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in AdolescentsCompletedNCT02726542Early Phase 1Results posted
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)TerminatedNCT02704403Phase 3Results posted
• Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and LipodystrophyCompletedNCT02684591Phase 2Results posted
• Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD SubjectsCompletedNCT02681055Phase 2Results posted
• CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial LipodystrophyCompletedNCT02654977Phase 2Results posted
• Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674 (Cilofexor), and the Effect of Food on GS-9674 Pharmacokinetics and PharmacodynamicsCompletedNCT02654002Phase 1Results posted
• A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)CompletedNCT02653300Phase 2Results posted
• Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)CompletedNCT02633956Phase 2Results posted
• Cardiometabolic Effects of Eplerenone in HIV InfectionTerminatedNCT02629094Phase 2Results posted
• Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD)TerminatedNCT02605616Phase 2Results posted
• The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver DiseaseCompletedNCT02546609Phase 2Results posted
• The Effect of HIT in Patients With Non-alcoholic Fatty Liver Disease/SteatohepatitisCompletedNCT02528305Not applicableResults posted
• Dietary Treatment Study of Pediatric NAFLDCompletedNCT02513121Not applicableResults posted
• Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3CompletedNCT02466516Phase 2Results posted
• JKB-121 for the Treatment of Nonalcoholic SteatohepatitisCompletedNCT02442687Phase 2Results posted
• Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced FibrosisCompletedNCT02421094Phase 2Results posted
• A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)CompletedNCT02413372Phase 2Results posted
• Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT02369536Not applicableResults posted
• Fatty Liver Study in Patients With Type II DiabetesTerminatedNCT02365233Phase 4Results posted
• A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.CompletedNCT02354976Phase 2Results posted
• ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLDCompletedNCT02330549Phase 2Results posted
• A Phase ll Study of IMM-124E for Patients With Non-alcoholic SteatohepatitisCompletedNCT02316717Phase 2Results posted
• BREATHID Octanoate Breath Test With or Without Methacetin Breath Test for Correlation With Biopsy in NASHCompletedNCT02314026Phase 2Results posted
• Effects of Pitavastatin on Insulin Sensitivity and Liver FatCompletedNCT02290106Not applicableResults posted
• Safety and Tolerability Study of SHP626 in Overweight and Obese AdultsCompletedNCT02287779Phase 1Results posted
• A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASHCompletedNCT02279524Phase 2Results posted
• A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic PatientsCompletedNCT02279407Phase 2Results posted
• Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLDTerminatedNCT02244944Phase 2Results posted
• Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver FibrosisCompletedNCT02217475Phase 2Results posted
• Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver DiseaseCompletedNCT02217345Phase 2Results posted
• Tesamorelin Effects on Liver Fat and Histology in HIVCompletedNCT02196831Not applicableResults posted
• Liver and Fat Regulation in Overweight Adolescent GirlsCompletedNCT02157974Phase 2/3Results posted
• The Role of Obstructive Sleep Apnea in Children With Fatty Liver DiseaseTerminatedNCT02134522Not applicableResults posted
• Ultrasound Method to Measure Fibrosis of the Liver in ChildrenTerminatedNCT02086708Not applicableResults posted
• A Study of IDN-6556 in Subjects With NAFLD and Raised TransaminasesCompletedNCT02077374Phase 2Results posted
• Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic PatientsCompletedNCT01975935Phase 2Results posted
• Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver DiseaseCompletedNCT01963845Phase 2Results posted
• Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance Biomarkers in Nonalcoholic Fatty Liver DiseaseTerminatedNCT01930123Phase 2Results posted
• Amlexanox for Type 2 Diabetes and ObesityTerminatedNCT01842282Phase 2Results posted
• Low Fat Vegan or American Heart Association Diets & Cardiovascular Risk in Obese 9-18 y.o. With Elevated CholesterolCompletedNCT01817491Not applicableResults posted
• Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD PatientsCompletedNCT01811472Phase 2Results posted
• Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin ECompletedNCT01792115Phase 2Results posted
• How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)?CompletedNCT01790984Not applicableResults posted
• Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic SyndromeCompletedNCT01787591Not applicableResults posted
• Ezetimibe Versus Placebo in the Treatment of Non-alcoholic SteatohepatitisCompletedNCT01766713Phase 2Results posted
• Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control GroupCompletedNCT01754714Phase 3Results posted
• Sonoelastography: Ultrasound Method to Measure Liver FibrosisCompletedNCT01747772Not applicableResults posted
• Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver DiseaseCompletedNCT01712711Phase 2Results posted
• Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitisTerminatedNCT01703260Phase 2Results posted
• Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)CompletedNCT01694849Phase 2Results posted
• Investigation of Synbiotic Treatment in NAFLDCompletedNCT01680640Not applicableResults posted
• Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With LipodystrophyCompletedNCT01679197Phase 2Results posted
• Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)TerminatedNCT01672866Phase 2Results posted
• Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic SteatohepatitisCompletedNCT01654549Phase 2Results posted
• The Effect of Protein-enriched Diet on Body Composition and AppetiteCompletedNCT01634048Not applicableResults posted
• Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal CirculationCompletedNCT01579162Not applicableResults posted
• Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in ChildrenCompletedNCT01529268Phase 2/3Results posted
• The Sleep, Liver Evaluation and Effective Pressure StudyCompletedNCT01482065Phase 2Results posted
• Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008)CompletedNCT01431521Phase 1Results posted
• Rifaximin in Fatty Liver DiseaseTerminatedNCT01355575Phase 4Results posted
• Insulin Resistance in Non-alcoholic Fatty Liver DiseaseTerminatedNCT01289639Not applicableResults posted
• Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) StudyCompletedNCT01285362Not applicableResults posted
• Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver DiseaseCompletedNCT01284634Phase 2Results posted
• The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)CompletedNCT01265498Phase 2Results posted
• Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)TerminatedNCT01244503Phase 2Results posted
• Liver Fat Quantification by Magnetic Resonance Imaging (MRI) - Prediction of Postoperative ComplicationsCompletedNCT01234714Results posted
• Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)CompletedNCT01154985Phase 2Results posted
• Colesevelam Versus Placebo in the Treatment of Nonalcoholic SteatohepatitisCompletedNCT01066364Phase 2Results posted
• LAGB as a Treatment for Morbid Obesity in AdolescentsCompletedNCT01045499Not applicableResults posted
• Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver DiseaseCompletedNCT01006889Phase 4Results posted
• Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of TreatmentCompletedNCT01002547Phase 4Results posted
• University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)CompletedNCT00994682Phase 4Results posted
• Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver DiseaseCompletedNCT00949403Early Phase 1Results posted
• Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT00940537Results posted
• Pioglitazone on Pancreatic Steatosis and Bone HealthCompletedNCT00855010Not applicableResults posted
• Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)TerminatedNCT00845845Phase 2Results posted
• A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)CompletedNCT00799578Phase 1/2Results posted
• The Effect of Growth Hormone Replacement on Liver FatCompletedNCT00774579Results posted
• Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty AcidsCompletedNCT00760513Phase 4Results posted
• Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C InfectionsTerminatedNCT00742326Phase 4Results posted
• Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)TerminatedNCT00736385Phase 4Results posted
• Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic SteatohepatitisCompletedNCT00680407Phase 2Results posted
• Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive ProceduresTerminatedNCT00678587Phase 3Results posted
• Role of Exenatide in NASH-a Pilot StudyCompletedNCT00650546Phase 2/3Results posted
• Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH)CompletedNCT00596934Phase 2Results posted
• Pentoxifylline in Patients With Nonalcoholic SteatohepatitisCompletedNCT00590161Phase 2Results posted
• Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)CompletedNCT00586313Not applicableResults posted
• Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver DiseaseTerminatedNCT00529204Phase 2Results posted
• Study of INT-747 in Patients With Diabetes and Presumed NAFLDCompletedNCT00501592Phase 2Results posted

← Fatty Liver overview